FDA Has 19 Applications Remaining With User Fees In 2004: 7 NMEs, 1 BLA
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
With seven first-cycle new molecular entities with user fee deadlines in November and December, FDA could surpass the total number of new molecular entities approved in 2003.